Cost-benefit analyses offend against the notion that life is priceless
Their Gradgrindian logic is off-putting, but also mind-opening

THE AIRLESS nooks under a man’s foreskin are a cosy spot for microbes. These can inflame the surrounding skin, helping viruses such as HIV to spread. In places where the disease is common and treatment is patchy, removing foreskins can be a cost-effective way to fight it. In parts of Africa, the benefits of circumcising adolescents can outweigh the costs by about 10 to 1, according to the Copenhagen Consensus Centre (CCC), a think-tank. The ratio rises above 40 to 1 in the worst-hit countries.
This article appeared in the Finance & economics section of the print edition under the headline “Do-gooders and do-besters”
Finance & economics
November 16th 2019- America’s public-sector pension schemes are trillions of dollars short
- Tighter production targets have failed to lift the price of oil
- The Trump administration is trying to reforge carmakers’ supply chains
- The case for a falling dollar
- The improved mood in financial markets
- Some Chinese firms turn out to have lied about their state pedigree
- Stiff sentences for bank fraud capture Italy’s sour public mood
- How Jim Simons became the most successful investor of all time
- Cost-benefit analyses offend against the notion that life is priceless

From the November 16th 2019 edition
Discover stories from this section and more in the list of contents
Explore the edition
Want to be a good explorer? Study economics
The battle to reduce risk has shaped centuries of ventures

Jane Street is chucked out of India. Other firms should be nervous
Around the world, marketmakers now face extra scrutiny

Japan has been hit by investing fever
Will old folk catch the bug?
Don’t invest through the rearview mirror
Markets are supposed to look forward; plenty of investors look back instead
Trump’s trade deals try a creative way to hobble China
To appease the world’s biggest market, countries must anger the world’s biggest trader
The great dealmaker is conspicuously short of trade deals
Donald Trump issues threats—and grants deadline extensions